<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02744079</url>
  </required_header>
  <id_info>
    <org_study_id>2016-6346</org_study_id>
    <nct_id>NCT02744079</nct_id>
  </id_info>
  <brief_title>Comparison of Healthy Diets on Breast Cancer Markers</brief_title>
  <acronym>KetoBreast</acronym>
  <official_title>A Pilot Presurgical Trial of Insulin Inhibition by a Ketogenic Diet in Operable Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albert Einstein College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Albert Einstein College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women post breast mass biopsy with ER+or ER- cancer will be randomized to two diets--goal of&#xD;
      45 of them to a ketogenic insulin inhibiting diet, 20 to a low fat diet with whole grains and&#xD;
      fruits and vegetables. The initial biopsy will be evaluated along with the surgical specimen&#xD;
      pathology to compare changes in biomarkers, particularly of proliferation (Ki-67) and&#xD;
      apoptosis (TUNEL).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A healthy diet has been defined in various ways. The investigators wish to compare the&#xD;
      effects of two diets on ER positive breast cancer tissues. The diets will be administered&#xD;
      between the time of diagnosis and the time of surgical removal. Both diets have been proposed&#xD;
      as healthy, but differ in their composition. One constitutes a low fat diet with extra fiber,&#xD;
      fruits and vegetable servings, while the other comprises a diet low in carbohydrate content,&#xD;
      aiming to lower insulin secretion. Patients will be randomized to each group, with 20&#xD;
      assigned to the low fat arm and 45 to the low carbohydrate arm.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 22, 2018</start_date>
  <completion_date type="Actual">August 25, 2020</completion_date>
  <primary_completion_date type="Actual">August 25, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>TUNEL comparison of each dietary intervention at surgical removal to measure change in apoptosis in tumor cells</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ki-67 comparison of each dietary intervention at surgical removal to measure change in proliferation of tumor cells</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Breast Neoplasms</condition>
  <arm_group>
    <arm_group_label>Low carbohydrate diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>45 subjects will receive a very low carbohydrate diet between a positive breast biopsy and surgical tumor removal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low fat diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 subjects will receive a lo fat diet between a positive breast biopsy and surgical tumor removal</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low carbohydrate diet</intervention_name>
    <description>45 subjects will be randomized to a dietary arm consisting of a complete, prepared very low carbohydrate diet, delivered to their homes, for the interval between positive breast biopsy and surgical tumor removal</description>
    <arm_group_label>Low carbohydrate diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low fat diet</intervention_name>
    <description>20 subjects will be randomized to a dietary arm consisting of a complete, prepared low fat diet, delivered to their homes, for the interval between positive breast biopsy and surgical tumor removal.</description>
    <arm_group_label>Low fat diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Women with biopsy proven breast cancer.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eugene J Fine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Albert Einstein College of Medicine of Yeshiva University</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Fine EJ, Segal-Isaacson CJ, Feinman RD, Herszkopf S, Romano MC, Tomuta N, Bontempo AF, Negassa A, Sparano JA. Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition. 2012 Oct;28(10):1028-35. doi: 10.1016/j.nut.2012.05.001. Epub 2012 Jul 26.</citation>
    <PMID>22840388</PMID>
  </reference>
  <reference>
    <citation>Jain R, Strickler HD, Fine E, Sparano JA. Clinical studies examining the impact of obesity on breast cancer risk and prognosis. J Mammary Gland Biol Neoplasia. 2013 Dec;18(3-4):257-66. doi: 10.1007/s10911-013-9307-3. Epub 2013 Nov 13. Review.</citation>
    <PMID>24221746</PMID>
  </reference>
  <reference>
    <citation>Fine EJ, Miller A, Quadros EV, Sequeira JM, Feinman RD. Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell Int. 2009 May 29;9:14. doi: 10.1186/1475-2867-9-14.</citation>
    <PMID>19480693</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>April 13, 2016</study_first_submitted>
  <study_first_submitted_qc>April 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2016</study_first_posted>
  <last_update_submitted>August 28, 2020</last_update_submitted>
  <last_update_submitted_qc>August 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Albert Einstein College of Medicine</investigator_affiliation>
    <investigator_full_name>Eugene Fine</investigator_full_name>
    <investigator_title>Professor of Radiology</investigator_title>
  </responsible_party>
  <keyword>diet</keyword>
  <keyword>dietary intervention</keyword>
  <keyword>carbohydrate restriction</keyword>
  <keyword>low carbohydrate</keyword>
  <keyword>fat restriction</keyword>
  <keyword>low fat</keyword>
  <keyword>cancer</keyword>
  <keyword>breast cancer</keyword>
  <keyword>pre-surgical window</keyword>
  <keyword>biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

